Class I
Drug Recall: Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for:
InvaGen Pharmaceuticals, Inc. · November 17, 2023
Reason for Recall
Defective Container: powder may leak out of the pouch
Product Description
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
Distribution
Nationwide within the United States
States Affected
NATIONWIDE
Quantity Affected
1240 boxes
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0220-2024
Status: completed
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.